glutathione/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
glutathione — decreases intracellular BCG burden in PBMC-derived granulomas (CFU)
Evidence strength: moderate.Finding“When compared to the placebo group, PBMCs isolated from individuals with T2DM who received L-GSH supplementation for 3-months had a significantly reduced burden of BCG.”
Quoted verbatim from Effects of Oral Liposomal Glutathione in Altering the Immune Responses Against Mycobacterium tuberculosis and the Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes.. - Study
- RCT
- Duration
- 3 months
- Dose
- oral liposomal reduced glutathione, 1260 mg/day (3 teaspoons, 15 ml, in two divided doses)
- Population
- Adults aged 18-65 with type 2 diabetes (HbA1c 7-13%); PBMCs drawn at 3 months, infected with M. bovis BCG in vitro, granulomas terminated at 15 days
Effects of Oral Liposomal Glutathione in Altering the Immune Responses Against Mycobacterium tuberculosis and the Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes.2021PMID:3415067410.3389/fcimb.2021.657775Permalink
To cite this finding: https://catalystproject.ai/e/01M5JEWYT1RS6SK3P0VVSV4CAK